CLEAVED DIAGNOSTIC CORPORATION

Medtech · Private

CRISPR-Cas12a molecular diagnostic for congenital cytomegalovirus detection from dried blood spots

Grants
$305K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · STTR Phase I: A Novel Iothermal CRISPR-Cas12a Platform for the Detection of Viruses$305,000
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1804TF HEALTH CORPORATION——
1805AFFINERGY, LLC——
1806CORAMI BIOTECH INC.—$230K
1807CLEAVED DIAGNOSTIC CORPORATION——
1808HALCYON BIOMEDICAL, INC.——
1809Savage Medical Inc.——
1810G5 BIOLOGICAL INNOVATIONS LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.